Talking to Lorena Kuri - European Medical Journal

Talking to Lorena Kuri

Season 01: episode 58

This week, GOLD speaks to Lorena Kuri, Director of Clinical Trial Diversity Strategy, Bristol-Myers-Squibb, who discusses how to address underrepresentation in clinical trials, how teams can prioritise belonging, and how her experience as a board member of WOCIP has shaped her perspective and ambitions.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?